【ChiCTR2500104800】Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
ChiCTR2500104800
正在进行
/
/
/
2025-06-24
/
/
Cholelithiasis
Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
To compare the outcomes of direct trocar versus Veress needle entry techniques in obese women during laparoscopic cholecystectomy.
随机平行对照
Ⅰ期
The patients will be divided into two equal groups by using lottery method.
Not stated
/
/
90
/
2025-07-01
2026-03-31
/
Obese women with body mass index >= 30 kg/m^2, having cholelithiasis, with an American society of Anesthesiology (ASA) status I and II will be included.;
请登录查看Men, non-obese women, Patients who had previous history of abdominal surgery, ASA status ≥ III, clinically obvious ongoing infection, those having poorly controlled type 2 diabetes mellitus, other comorbid conditions like hypertension and chronic renal failure, concomitant cardiopulmonary severe disease, abnormalities with the clotting/bleeding and the patients who are unfit to undergo general anesthesia.;
请登录查看Combine Military Hospital Quetta
/
Combine Military Hospital Quetta的其他临床试验
Combined Military Hospital Quetta的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
